Investment Tools And Research To Help Make You A More Confident And Profitable Trader. FREE 30 Day Trial
or

Novo Nordisk A/S ADR (NVO)

Novo Nordisk A/S ADR (NVO)
89.78 -1.17 (-1.29%) 13:22 ET [NYSE]
89.76 x 51 89.79 x 100
Realtime by (Cboe BZX)
89.76 x 51 89.79 x 100
Realtime 91.11 +0.16 (+0.18%) 09:30 ET
Quote Overview for Wed, Feb 26th, 2025
Watch
    Add or delete the symbol from one or more Watchlists.
Day Low
89.59
Day High
91.12
Open 91.03
Previous Close 90.95 90.95
Volume 4,334,827 4,334,827
Avg Vol 8,521,075 8,521,075
Stochastic %K 84.94% 84.94%
Weighted Alpha -32.31 -32.31
5-Day Change +6.67 (+8.00%) +6.67 (+8.00%)
52-Week Range 77.82 - 148.15 77.82 - 148.15
  • 1D
  • 5D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
  • MAX
Full Chart
  • OHLC Bars
  • Colored OHLC Bars
  • HLC Bars
  • Candlestick Hollow
  • Candlestick Open-to-Close
  • Candlestick Close-to-Close
  • Heikin-Ashi
  • Line Chart
  • Area Chart
  • Renko
  • Column
  • Baseline
  • Line Break
  • Range
  • Kagi
  • Point And Figure
Realtime quote and/or trades are not sourced from all markets.

Fundamentals

See More
  • Market Capitalization, $K 408,141,056
  • Shares Outstanding, K 4,487,532
  • Annual Sales, $ 42,108 M
  • Annual Income, $ 14,643 M
  • EBIT $ 18,609 M
  • EBITDA $ 21,380 M
  • 60-Month Beta 0.45
  • Price/Sales 9.65
  • Price/Cash Flow 23.34
  • Price/Book 19.54

Options Overview Details

View History
  • Implied Volatility 40.87% ( -0.48%)
  • Historical Volatility 46.43%
  • IV Percentile 75%
  • IV Rank 49.28%
  • IV High 58.88% on 12/19/24
  • IV Low 23.37% on 06/12/24
  • Put/Call Vol Ratio 0.48
  • Today's Volume 19,610
  • Volume Avg (30-Day) 44,851
  • Put/Call OI Ratio 0.66
  • Today's Open Interest 368,903
  • Open Int (30-Day) 374,260

Analyst Rating / Earnings Estimates

Current Rating
See More
Moderate Buy
Based on 16 analysts offering recommendations.
Earnings Estimates - Current Qtr 03/31/25
See More
  • Average Estimate 0.96
  • Number of Estimates 3
  • High Estimate 1.00
  • Low Estimate 0.90
  • Prior Year 0.83
  • Growth Rate Est. (year over year) +15.66%

Price Performance

See More
Period Period Low Period High Performance
1-Month
77.82 +15.74%
on 02/14/25
Period Open: 87.97
93.80 -3.98%
on 02/25/25
+2.10 (+2.39%)
since 01/24/25
3-Month
77.82 +15.74%
on 02/14/25
Period Open: 106.13
112.52 -19.95%
on 12/11/24
-16.06 (-15.13%)
since 11/26/24
52-Week
77.82 +15.74%
on 02/14/25
Period Open: 123.49
148.15 -39.20%
on 06/25/24
-33.42 (-27.06%)
since 02/26/24

Most Recent Stories

More News
Is This Penny Stock’s 525% Upside Potential an Attainable Goal?

Skye Bioscience is trying to establish a presence in the weight-loss drug market.

SKYE : 2.86 (-1.04%)
NVO : 89.78 (-1.29%)
$SPX : 5,964.53 (+0.16%)
LLY : 909.78 (+0.88%)
Hims & Hers Stock Is Plunging on Weight-Loss Drug Halt. Should You Buy the Dip?

Concerns over near-term profit margins and the loss of potential revenue from compounded semaglutide weigh on Hims & Hers stock.

HIMS : 41.25 (+3.49%)
NVO : 89.78 (-1.29%)
Wall Street Thinks This Weight-Loss Drug Stock Could More Than 3X Over the Next 12 Months -- and It's Not Eli Lilly or Novo Nordisk

Few big pharma stocks have been bigger winners over the last three years than Eli Lilly and Novo Nordisk . Lilly now ranks as the largest drugmaker in the world, with a market cap of $844 billion, after...

VKTX : 28.28 (-0.14%)
NVO : 89.78 (-1.29%)
MRK : 89.09 (-2.56%)
LLY : 909.78 (+0.88%)
Prediction: These Could Be the Best-Performing Value Stocks Through 2030

These two stocks are poised to crush the market thanks to their outsize growth prospects and dirt cheap valuations.

NVO : 89.78 (-1.29%)
PFE : 26.39 (-1.31%)
Why Novo Nordisk Stock Popped on Friday

Novo Nordisk (NYSE: NVO) stock ran up 3.5% through 10:05 a.m. ET Friday morning on some good news for it (and for Eli Lilly ) that's also probably bad news for Hims & Hers Health (NYSE: HIMS) .

NVO : 89.78 (-1.29%)
HIMS : 41.25 (+3.49%)
LLY : 909.78 (+0.88%)
Digesting Super Bowl Ads, Dunkin' & Starbucks Plans, and Some Weight Loss Drug News

The big game didn't live up to the big billing, but there was plenty to take in during commercial breaks and halftime.

SBUX : 112.91 (-1.47%)
HIMS : 41.25 (+3.49%)
NVO : 89.78 (-1.29%)
LLY : 909.78 (+0.88%)
MORN : 322.60 (-0.19%)
UBER : 75.99 (+1.39%)
DASH : 199.95 (+4.54%)
MCD : 305.70 (-1.62%)
CART : 42.94 (-11.97%)
Digging Into What Hershey and Eli Lilly Told Investors

In this podcast, Motley Fool analyst Bill Barker and host Ricky Mulvey discuss:

MDLZ : 63.51 (-3.60%)
NVDA : 131.32 (+3.70%)
NVO : 89.78 (-1.29%)
LLY : 909.78 (+0.88%)
TSM : 193.93 (+2.41%)
HSY : 171.41 (-4.05%)
PLTR : 90.32 (+2.82%)
3 Hot Stocks That Have Already Doubled in 2025

It may be early, but some blazing investments have already delivered wealth-altering gains in this young year.

NVDA : 131.32 (+3.70%)
NVO : 89.78 (-1.29%)
HIMS : 41.25 (+3.49%)
LLY : 909.78 (+0.88%)
WRD : 24.07 (+7.79%)
FUBO : 3.79 (-1.30%)
DIS : 112.24 (+1.55%)
These 3 Stocks Just Announced Major Dividend Hikes

See which three stocks just raised their dividend payments by over 15%. On firm now has a sky-high indicated yield of over 10%.

AB : 37.71 (+0.13%)
NVO : 89.78 (-1.29%)
RCL : 245.87 (+3.49%)
Novo Nordisk Shares Near New 52-Week Low: Analysts See Big Upside

Novo Nordisk shares are closing in on a new 52-week low. Is the stock gearing up for a recovery with sentiment currently low?

NVO : 89.78 (-1.29%)
HIMS : 41.25 (+3.49%)
LLY : 909.78 (+0.88%)

Barchart Technical Opinion

The Barchart Technical Opinion rating is a 56% Sell with a Weakening short term outlook on maintaining the current direction.

Long term indicators fully support a continuation of the trend.

See More Share

Business Summary

Bagsv'rd, Denmark-based Novo Nordisk is a global healthcare company and a leader in the worldwide diabetes market. The company is also a key player in hemophilia care, growth hormone therapy, hormone replacement therapy and obesity.Novo Nordisk operates through two segments: Diabetes and obesity care...

See More

Key Turning Points

3rd Resistance Point 98.30
2nd Resistance Point 96.05
1st Resistance Point 93.50
Last Price 89.79
1st Support Level 88.70
2nd Support Level 86.45
3rd Support Level 83.90

See More

52-Week High 148.15
Fibonacci 61.8% 121.28
Fibonacci 50% 112.99
Fibonacci 38.2% 104.69
Last Price 89.78
52-Week Low 77.82

See More

Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.
Use your up/down arrows to move through the symbols.

Free Barchart Webinar

Mastering Fibonacci: The Hidden Order in Market Movements